NFKB1 and ovarian cancer: A major contributor to the acquired chemoresistance of ovarian cancer cells is the increased expression of NFκB-dependent chemokines that is induced by the platinum-based drugs carboplatin and cisplatin, and by the mitotic inhibitors docetaxel and paclitaxel [29,80,81,82,83].